Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.00 (0.00%)
Bid:
0.021
Ask:
0.025
Spread: 0.004 (19.048%)
Market Cap: £2.16m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

Warrant Exercise

15 Feb 2021 15:54

RNS Number : 1605P
Sunrise Resources Plc
15 February 2021
 

15 February 2021

SUNRISE RESOURCES PLC

("Sunrise" or "the Company")

 

Warrant Exercise

 

Sunrise Resources plc, the AIM-traded company focusing on the development of its CS Pozzolan-Perlite Project in Nevada, USA, announces it has received notice to exercise 750,000 warrants ("the "Warrants").

 

Each Warrant entitles the holder to subscribe for one new ordinary share of 0.1 pence each in the Company (a "Warrant Share") at a price of 0.11 pence per Warrant Share and payment has been received by the Company.

 

The Warrant Shares will rank pari passu with the existing ordinary shares and application will be made to the London Stock Exchange for the Warrant Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on or around Friday 19 February 2021.

 

 

Total Voting Rights

 

For the purposes of the Disclosure and Transparency Rules of the Financial Conduct Authority, the Board of Sunrise hereby notifies the market that on Admission, the Company's issued share capital will consist of 3,695,860,238 ordinary shares with a nominal value of 0.1p each, with voting rights. The Company does not hold any Ordinary Shares in Treasury.

 

Therefore, the total number of ordinary shares in the Company with voting rights will be 3,695,860,238. This figure may be used by Shareholders in the Company as denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

This announcement contains inside information as defined in Article 7 of EU Regulation 596/2014. 

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

 

Tel: +44 (0)207 469 0930

 

 

Shares in the Company trade on AIM. EPIC: "SRES". Website: www.sunriseresourcesplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFDFIIEFSEIE
Date   Source Headline
14th Feb 202511:00 amRNSANNUAL REPORT & NOTICE OF 2025 AGM
13th Feb 20251:27 pmRNS-RUPDATED WEBSITE, PRESENTATION & CEO INTERVIEW
13th Feb 20259:46 amRNSUpdate - Pioche Sepiolite Project
13th Feb 20259:08 amRNSFinal Results
27th Dec 20243:58 pmRNSPioche Sepiolite Project – Tolsa Option
16th Dec 20249:29 amRNSCS PROJECT BULK SAMPLE – CUSTOMER TRIALS
5th Dec 20247:00 amRNSUPDATE ON THE COMPANY’S NATURAL POZZOLAN PROJECTS
2nd Dec 202410:12 amRNSTotal Voting Rights
27th Nov 20247:00 amRNSSALE OF CROW SPRINGS DIATOMITE CLAIMS
13th Nov 20244:28 pmRNSIssue and Allotment of Shares following Conversion
26th Sep 20247:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
2nd Sep 20249:17 amRNSTotal Voting Rights
19th Aug 20243:54 pmRNSIssue of Equity and Total Voting Rights
13th Aug 20247:00 amRNSExploration Update – Pioche Sepiolite Project
1st Aug 20247:00 amRNSTotal Voting Rights
15th Jul 202412:27 pmRNSHolding(s) in Company
12th Jul 20245:33 pmRNSHolding(s) in Company
12th Jul 202411:00 amRNSDrill Start – Pioche Sepiolite Project
1st Jul 20249:24 amRNSPlacing & Subscription to Raise £201,500 & TVR
3rd Jun 20247:00 amRNSTotal Voting Rights
30th May 202411:14 amRNSHalf-year Report
29th May 20247:00 amRNSPioche Sepiolite Project, Nevada, USA
24th May 20243:00 pmRNSIssue of Ordinary Shares following Conversion
24th May 20247:00 amRNSCrow Springs Diatomite Project Update
16th May 20249:54 amRNSGarfield Royalty Interest
2nd Apr 20247:00 amRNSSALE OF DIATOMITE CLAIMS
28th Mar 20247:00 amRNSTotal Voting Rights
7th Mar 202411:20 amRNSDIRECTOR DEALING
5th Mar 20247:00 amRNSIssue of Shares following Conversion & TVR
29th Feb 202410:11 amRNSTotal Voting Rights
23rd Feb 202412:27 pmRNSDIRECTOR DEALING, ISSUE OF EQUITY & TVR
23rd Feb 202411:35 amRNSVoting at AGM
22nd Feb 202412:32 pmRNSResult of AGM
26th Jan 202410:00 amRNSANNUAL REPORT AND NOTICE OF 2024 AGM
24th Jan 20247:00 amRNSFinal Results
18th Jan 20247:00 amRNSPioche Sepiolite Project
27th Dec 202310:31 amRNSPioche Sepiolite Project
4th Dec 20231:55 pmRNSGarfield Royalty Interest
1st Dec 20237:00 amRNSInvestor Presentation
22nd Nov 20239:51 amRNSResult of Meeting
7th Nov 20237:00 amRNSProposed Sub-Division of Share Capital
31st Oct 20237:00 amRNSReese Ridge Zinc-Lead-Silver (-Gallium) Project
27th Sep 20237:00 amRNSPioche Project Update
15th Sep 20237:00 amRNSMarket Study and Pozzolan Project Update
31st Aug 20236:09 pmRNSTotal Voting Rights
11th Aug 202312:51 pmRNSIssue of Shares following Conversion & TVR
11th Aug 202312:45 pmRNSISSUE OF WARRANTS
3rd Aug 20234:20 pmRNSHolding(s) in Company
25th Jul 20237:00 amRNSPioche Resource Drilling Programme in Progress
4th Jul 202312:38 pmRNSIssue of Equity & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.